STIM 0.75 (-57.87%)
US64131A1051Medical Diagnostics & ResearchDiagnostics & Research

Neuronetics (STIM) Competitor Comparison

We are evaluating the key criteria listed to compare Neuronetics (STIM) against its competitors in the Diagnostics & Research industry.

Performance 10 years - STIM ranking 52 / 58

These are the competitors of Neuronetics in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.49K
3. Medpace Holdings MEDP
1.27K
4. RadNet RDNT
798.86
5. IDEXX Laboratories IDXX
649.34
6. Natera NTRA
536.5
7. DexCom DXCM
526.77
8. Icon ICLR
506.69
9. Mettler-Toledo MTD
433.33
10. Danaher DHR
431.12
11. Thermo Fisher Scientific TMO
389.84
12. IQVIA Holdings IQV
325.19
13. Charles River Laboratories CRL
253.51
14. PerkinElmer PKI
247.07
15. Agilent Technologies A
245.21
16. Exact Sciences EXAS
239.75
17. Twist Bioscience TWST
238.23
18. NeoGenomics NEO
231
19. Waters WAT
219.32
20. Fulgent Genetics FLGT
159.72
21. Laboratory Corp of America Holdings LH
155.37
22. CareDx CDNA
148.44
23. Quest Diagnostics DGX
145.66
24. Syneos Health SYNH
113.83
25. Qiagen QGEN
83.36
26. Meridian Bioscience VIVO
60.69
27. National Research NRC
51.18
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Guardant Health GH
4.5
30. Neogen NEOG
1.31
31. Inotiv NOTV
-20.85
32. Illumina ILMN
-26.32
33. Myriad Genetics MYGN
-26.56
34. Olink Holding OLK
-26.82
35. Sotera Health SHC
-46.11
36. Bioventus BVS
-49.74
37. Anixa Biosciences ANIX
-49.76
38. Sera Prognostics SERA
-50.7
39. Global Cord Blood CO
-66.57
40. Pacific Biosciences of California PACB
-67.62
41. MaxCyte MXCT
-75.4
42. DarioHealth DRIO
-75.47
43. MDxHealth MDXH
-78.68
44. bioAffinity Technologies BIAF
-78.81
45. Enzo Biochem ENZ
-79.69
46. Exagen XGN
-79.88
47. Co-Diagnostics CODX
-81.33
48. Personalis PSNL
-86.19
49. Trinity Biotech TRIB
-87.63
50. Psychemedics PMD
-88.22
51. Biodesix BDSX
-88.3
52. Neuronetics STIM
-92.88
53. SeqLL SQL
-95.22
54. Prenetics Global PRE
-95.41
55. Aspira Womens Health AWH
-97.44
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.57
58. Precipio PRPO
-99.8

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.